Dayal, Lentz receive R01 to investigate COVID-19 clotting
Sanjana Dayal, PhD, and Steven Lentz, MD, PhD, received a $3.36M R01 grant from the National Institute of Allergy and Infectious Diseases. The grant, titled…
Steven Lentz
-
-
Iowa MSTP renews grant, preserves essential training
When Robert E. Fellows, MD, PhD, professor emeritus, started the Iowa Medical Scientist Training Program (MSTP) in 1977, no one anticipated it would become one…
-
Steven Lentz, MD, PhD, steps down as Hematology Section Chief
After three years as Section Chief of Hematology in the Division of Hematology, Oncology, and Blood & Marrow Transplantation, Steven Lentz, MD, PhD, Henry Hamilton…
-
Potential new target may aid post-stent recovery
Neointimal hyperplasia is a well-documented remodeling of the innermost vascular layer after vascular interventions and is a significant clinical outcome for many, especially people who…
-
HOBMT Leadership Change
I am pleased to announce that we have implemented a new leadership structure for the Division of Hematology, Oncology, and Blood & Marrow Transplantation (HOBMT)….
-
Lentz delivers Sherry Lecture at AHA
Steven R. Lentz, MD, PhD, Hamilton Chair in Hematology and Hematology Section Chief, presented the 2018 Sol Sherry Distinguished Lecture in Thrombosis at the American…
-
Lentz and Zahr Editorial in NEJM
Dr. Steve Lentz and Dr. Firas Zahr shared a byline recently in an editorial published by the New England Journal of Medicine. Drs. Lentz and…
-
Lentz Named Chair of ATVB Council
Dr. Steven Lentz has recently been elected Chair of the Council on Arteriosclerosis, Thrombosis and Vascular Biology (ATVB), one of the largest and most active…
